Pure Global
NCT06276959

The Effectiveness of iTero Element 5D NIRI System in Early Proximal Caries Detection in Permanent Teeth

Comparison of Near-infrared Imaging With Cone Beam Computed Tomography for Proximal Caries Detection in Permanent Dentition: An in Vivo Study.
West China Hospital·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dental Caries
Drug/Device/Intervention
intraoral scanning
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
West China Hospital
Location
Chengdu, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2023
End date
Mar 01, 2025
Enrollment
120 participants
Primary outcome

proximal caries positive site diagnosed by CBCT,proximal caries positive site diagnosed by near-infrared imaging (NIRI),proximal caries positive site diagnosed by unaided visual examination (UVE)

Summary

As a new emerging technology for the diagnosis of dental caries, near-infrared imaging
 requires further research and validation to determine its effectiveness. This study aims to
 compare near-infrared imaging with cone-beam computed tomography (CBCT) and validate the
 specificity and sensitivity of near-infrared imaging in diagnosing early proximal caries
 using large-scale clinical data through cross-sectional studies.

ICD-10 classifications
Dental cariesOther dental cariesDental caries, unspecifiedCaries of dentineCaries limited to enamel
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06276959
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06276959 through Pure Global AI's free database. This phase not specified trial is sponsored by West China Hospital and is currently Recruiting. The study focuses on Dental Caries. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.